On Tuesday shares of Celgene Corporation (NASDAQ:CELG) closed at $122.15. Company’s sales growth for last 5 years was 23.30% and EPS growth for next 5 years is recorded as 25.50%. Celgene Corporation (NASDAQ:CELG) announced that data from a phase II study (n = 166) on Crohn’s disease candidate, GED-0301, were published in The New England Journal of Medicine. The double-blind, placebo-controlled, multicenter phase II study evaluated the use of GED-0301 in patients suffering from moderate-to-severe Crohn’s disease with documented inflammatory lesions in the terminal ileum and/or right colon.
Pfenex Inc. (NYSEMKT:PFNX) in last trading activity increased 19.90% to close at $17.35. Company weekly performance is 22.61% while its quarterly performance stands at 146.80%. Pfenex Inc. (NYSEMKT:PFNX) is 8.57% away from its 52 week high. Pfenex Inc. (NYSEMKT:PFNX) announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) in connection with the exclusive collaboration agreement executed by the company on February 9, 2014 with Hospira, Inc. to develop and commercialize, PF582, Pfenex’s biosimilar product candidate to Genentech’s Lucentis (ranibizumab injection).
On last trading day American Vanguard Corp. (NYSE:AVD) increased 0.58% to close at $10.48. Its volatility for the week is 2.23% while volatility for the month is 4.15%. AVD’s sales growth for past 5 years was 7.70% and its EPS growth for past 5 years was 22.90%. American Vanguard Corp. (NYSE:AVD) monthly performance is -9.34%. Topeka Capital Markets upgraded shares of American Vanguard Corp. (NYSE:AVD) from a hold rating to a buy rating in a research note issued to investors on 12 March 2015.
Tesla Motors Inc (NASDAQ:TSLA) has 0.10% insider ownership while its institutional ownership stands at 63.90%. In last trading activity company’s stock closed at $201.72. Tesla Motors Inc (NASDAQ:TSLA) is getting ready to roll out its new Model X and the car has been spotted getting road-tested on the highways of California.
On last trading day Boardwalk Pipeline Partners, LP (NYSE:BWP) increased 0.68% to close at $16.22. Its volatility for the week is 1.57% while volatility for the month is 1.98%. BWP’s sales growth for past 5 years was 6.30% and its EPS growth for past 5 years was 3.80%. Boardwalk Pipeline Partners, LP (NYSE:BWP) monthly performance is -2.35%.Boardwalk Pipelines, the wholly owned subsidiary of Boardwalk Pipeline Partners LP (NYSE: BWP) said March 10 that it priced a public offering of an additional $250 million, in aggregate principal amount, of senior notes. The 4.95% senior notes are due Dec. 15, 2024. They are in addition to $350 million, in aggregate principal amount, of the 4.95% notes due Nov. 26, 2024.